Ironwood Pharmaceuticals, Inc. (FRA:I76)
Germany
· Delayed Price · Currency is EUR 3.000
-0.200 (-6.25%)
At close: Dec 5, 2025
Ironwood Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 28.55 | 0.88 | -1,002 | 175.07 | 528.45 | 106.18 | Upgrade
|
| Depreciation & Amortization | 1.91 | 2.01 | 1.58 | 1.42 | 1.52 | 2.36 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.09 | 0.08 | - | 0 | 0.09 | 0.47 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 1,095 | - | - | 1.2 | Upgrade
|
| Stock-Based Compensation | 17.99 | 29.85 | 32.01 | 27.05 | 22.28 | 31.18 | Upgrade
|
| Other Operating Activities | 85.41 | 69.99 | 45.36 | 67.41 | -308.18 | 28.39 | Upgrade
|
| Change in Accounts Receivable | -44.16 | 47.24 | 0.92 | 7.99 | 7.71 | 4.09 | Upgrade
|
| Change in Inventory | - | - | - | - | - | 0.65 | Upgrade
|
| Change in Accounts Payable | 0.77 | -20.21 | 12.38 | -8.12 | -2.64 | -7.52 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | - | -0.88 | Upgrade
|
| Change in Other Net Operating Assets | -22.88 | -26.29 | -2.03 | 2.94 | 12.66 | 2.72 | Upgrade
|
| Operating Cash Flow | 67.68 | 103.55 | 183.43 | 273.76 | 261.9 | 168.84 | Upgrade
|
| Operating Cash Flow Growth | -45.49% | -43.55% | -33.00% | 4.53% | 55.12% | 1474.23% | Upgrade
|
| Capital Expenditures | -0.04 | -0.14 | -0.27 | -0.14 | -0.27 | -1.84 | Upgrade
|
| Cash Acquisitions | - | - | -1,026 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.04 | -0.14 | -1,026 | -0.14 | -0.27 | -1.84 | Upgrade
|
| Long-Term Debt Issued | - | 150 | 400 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -265 | -100 | -120.7 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -15 | -115 | 300 | -120.7 | - | - | Upgrade
|
| Issuance of Common Stock | 0.3 | 11.01 | 6.36 | 9.54 | 19.58 | 18.55 | Upgrade
|
| Repurchase of Common Stock | - | -0.74 | - | -126.39 | -24.13 | - | Upgrade
|
| Other Financing Activities | -0.09 | -2.25 | -29.2 | - | - | - | Upgrade
|
| Financing Cash Flow | -14.79 | -106.97 | 277.16 | -237.55 | -4.55 | 18.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.66 | -0.03 | -0.05 | - | - | - | Upgrade
|
| Net Cash Flow | 52.2 | -3.6 | -565.78 | 36.07 | 257.08 | 185.54 | Upgrade
|
| Free Cash Flow | 67.65 | 103.41 | 183.15 | 273.63 | 261.63 | 166.99 | Upgrade
|
| Free Cash Flow Growth | -45.36% | -43.54% | -33.06% | 4.58% | 56.67% | 4622.68% | Upgrade
|
| Free Cash Flow Margin | 19.96% | 29.43% | 41.37% | 66.64% | 63.23% | 42.87% | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.65 | 1.18 | 1.47 | 1.59 | 1.04 | Upgrade
|
| Cash Interest Paid | 32.56 | 32.56 | 13.55 | 5.75 | 7.22 | 7.22 | Upgrade
|
| Cash Income Tax Paid | 8.41 | 8.41 | 9.95 | 4.62 | 3.45 | 1.85 | Upgrade
|
| Levered Free Cash Flow | 39.12 | 80.31 | 204.13 | 161.46 | 170.05 | 98.04 | Upgrade
|
| Unlevered Free Cash Flow | 60.23 | 101.11 | 217.5 | 166.21 | 189.52 | 116.46 | Upgrade
|
| Change in Working Capital | -66.27 | 0.74 | 11.28 | 2.82 | 17.73 | -0.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.